Showing results (131-140 of 5,479) with videos related to
Sort By:
Pageof 548
Pharmacotherapy|January 27, 2007
Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidolJames E Tisdale, Richard Kovacs, Deming Mi, et al.Pharmacotherapy|January 1, 1991
Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related diseaseS J Matthews, R J Cersosimo, M L SpivackPharmacotherapy|April 28, 2007
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatmentMark A Munger, Tien M H Ng, Benjamin W Van TassellPharmacotherapy|April 28, 2007
Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratioTammy Burns, Stephanie R Maciejewski, William R Hamilton, et al.Pharmacotherapy|April 28, 2007
Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary interventionKristin Watson, Amy L Seybert, Melissa I Saul, et al.Pharmacotherapy|April 28, 2007
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapyDeborah DeEugenio, Louis Kolman, Matthew DeCaro, et al.Pharmacotherapy|April 28, 2007
Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemiaJames M McKenney, Domenic SicaPharmacotherapy|September 27, 2006
Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapyC A Bond, Cynthia L RaehlPharmacotherapy|September 27, 2006
Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolismFreddy M Creekmore, Gary M Oderda, Robert C Pendleton, et al.Pharmacotherapy|September 27, 2006
Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacinScott Mathews, Jean Cole, Russell A RyonoPageof 548